Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Dodge & Cox Stock I

Dodge & Cox Balanced Composite

Fidelity Large Cap Stock

Dodge & Cox Worldwide US Stock A EUR

VanEck Pharmaceutical ETF

Pacific Select Large-Cap Value I

ClearBridge Value

ClearBridge All Cap Value A

ClearBridge All Cap Value

ClearBridge Value C

Fidelity Mega Cap Stock

Strategic Advisers U.S. Total Stock

Dodge & Cox Balanced I

Fidelity Series Large Cap Stock

Strategic Advisers Fidelity US TtlStk

Fidelity Growth & Income

ClearBridge Large Cap Value I

ClearBridge Large Cap Value

Douglas C. Lane & Assoc. Core Equity

Fidelity Advisor Capital Development O

Dodge & Cox

FMR Inc

Envestnet Asset Management Inc

Bank of America Corp

Goldman Sachs Group Inc

JPMorgan Chase & Co

Nuveen Asset Management, LLC

Northern Trust Corp

Raymond James & Associates

Wells Fargo & Co

Van Eck Associates Corporation

Bain Capital Public Equity Management II, LLC

ClearBridge Advisors, LLC

Harding Loevner L.P.

Fisher Asset Management, LLC

Wellington Management Company LLP

Aristotle Capital Management LLC

OZ Management LLC

Douglas Lane & Associates, LLC

Morgan Stanley - Brokerage Accounts

Haleon plc

Mr. Brian James McNamara

CEO & Executive Director

Mr. Tobias Hannes Hestler

Executive Officer

Ms. Dawn Amanda Allen

CFO & Director

Ms. Claire  Dickson

Chief Digital & Technology Officer

Ms. Sonya  Ghobrial

Head of Investor Relations

Mr. Adrian Charles Morris

General Counsel

Ms. Tamara  Rogers

Chief Marketing Officer

Ms. Line  De Decker

Chief Human Resources Officer

Mr. Filippo  Lanzi

President of EMEA & LatAm

Mr. Keith  Choy

President of Asia Pacific

Haleon plc (HLN) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

HLN's latest dividend is 0.05142 USD on August 16, 2024

HLN Stock Discussion Forum and Message Board

News for NYSE: HLN